Apolipoprotein E polymorphism in Pick's disease and in Huntington's disease

Neurobiology of Aging

Volumn 21, Issue 4, 2000, Pages 555-558

  Kálmán, János ^a   Juhász, Anna ^a   Majtényi, Katalin ^b   Rimanóczy, Ágnes ^a   Jakab, Katalin ^a   Gárdián, Gabriella ^a   Raskó, István ^c   Janka, Zoltán ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b NATIONAL INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Hungary)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Allele polymorphism; Apolipoprotein E4; Hungarian population; Huntington's disease; Pick's disease

Indexed keywords

APOLIPOPROTEIN E;

ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HUNGARY; HUNTINGTON CHOREA; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PICK PRESENILE DEMENTIA; PRIORITY JOURNAL; RISK FACTOR;

AGED; ALLELES; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; FEMALE; GENOTYPE; HUMANS; HUNGARY; HUNTINGTON DISEASE; MALE; MIDDLE AGED; NEURONS; PICK DISEASE OF THE BRAIN; POLYMORPHISM, GENETIC; TAU PROTEINS;

EID: 0343090751     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(00)00150-0     Document Type: Article

References (32)

1. Broholm J., Cassiman J.J., Crauford D., et al. Guidelines for molecular genetics predictive test in Huntington's disease. Neurology. 44:1986;1533-1536.
2. Buée-Scherrer V., Hof P.R., Buée L., et al. Hyperphosphorylated tau proteins differentiate corticobasal degeneration and Pick's disease. Acta Neuropathol. 91:1996;351-359.
3. Clark L, Wilhelmsen KC. The genetics of Pick complex and adult onset dementia. In: Kertész A, Munoz D. Pick's Disease and Pick Complex. New York: Wiley-Liss Inc., 1998. p. 269-80.
4. Corder E.H., Saunders A.M., Strittmatter W.J., et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 261:1993;921-923.
5. Davies K.E. Human genetic diseases. A practical approach. 1986;IRL Press, Oxford.
6. Delacourte A., Robitaille Y., Sergeant N., et al. Specific pathological tau protein variants characterize Pick's disease. J Neuropath Exp Neur. 55:1996;159-168.
7. Farrer L.A., Abraham C.R., Volicer L., et al. Allele E4 of apolipoprotein E shows a dose effect on age at onset of Pick's disease. Exp Neurol. 136:1995;162-170.
8. Frisoni G.B., Calabresi L., Geroldi C., et al. Apolipoprotein E epsilon 4 allele in Alzheimer's disease and vascular dementia. Dementia. 5:1994;240-242.
9. Groen J.J., Endtz L.J. Hereditary Pick's disease. Second reexamination of the large family and discussion of the hereditary cases, with particular reference to electroencephalography, and computerized tomography. Brain. 105:1982;443-459.
10. Hallman D.M., Boerwinkle E., Saha N., et al. The apolipoprotein E polymorphism A comparison of allele frequencies and effects in nine populations . Am J Hum Genet. 49:1991;338-349.
11. Hardy J., Crook R., Prihar G., Roberts G., Raghavan R., Rerrz R. Senile dementia of the Lewy body type has an apolipoprotein E epsilon 4 allele frequency intermediate between controls and Alzheimer's disease. Neurosci Lett. 182:1994;1-2.
12. Hof P.R., Bouras C., Perl D.P., Morrison J.H. Quantitative neuropathologic analysis of Pick's disease cases cortical distribution of Pick bodies and coexistence of Alzheimer's disease . Acta Neuropathol. 87:1994;115-124.
13. Jackson D.P., Lewis F.A., Taylor G.R., Boylston A.W., Quirque P. Tissue extraction of DNA and RNA and analysis by the PCR. J Clin Pathol. 43:1990;499-504.
14. Jones A.L., Wood J.D., Harper P.S. Huntington's disease advances in molecular and cell biology . J Inherit Metab Dis. 20:1997;125-138.
15. Kato S., Nakamura H. Presence of two different fibril subtypes in the Pick body an immunoelectron microscopic study . Acta Neuropathol. 81:1990;125-129.
16. Kálmán J., Juhász A., Császár A., et al. Apolipoprotein E allele frequencies in patients with late-onset sporadic Alzheimer's dementia in Hungary. Acta Neurol Scand. 95:1997;56-59.
17. Kálmán J., Juhász A., Császár A., et al. Increased apolipoprotein E4 allele frequency is associated with vascular dementia in the Hungarian population. Acta Neurol Scand. 98:1998;166-168.
18. Martinoli M.G., Trojanowski J.Q., Schmidt M.L., et al. Association of apolipoprotein epsilon 4 allele and neuropathologic findings in patients with dementia. Acta Neuropathol. 90:1995;239-243.
19. Mendez M.F., Selwood A., Mastri A.R., Frey W.H. Pick's disease versus Alzheimer's disease, a comparison of clinical characteristics. Neurology. 43:1993;259-262.
20. Miller B.L., Boone K., Mishkin F., Swartz R., Koras N., Kushii J. Clinical, and Neuropsychological features of frontotemporal dementia. Kertész A., Munoz D. Pick's disease and Pick complex. 1998;23-31 Wiley-Liss Inc, New York.
21. Paulus W., Bancher C., Jellinger K. Microglial reaction in Pick's disease. Neurosci Lett. 161:1993;89-92.
22. Polvikovski T., Sulkava R., Haltia M., et al. Apolipoprotein E, dementia and cortical deposition of β-amyloid protein. New Engl J Med. 333:1995;1242-1247.
23. Prusiner SB, Hsia KK, Bredesen DE, Dearmond S, McKendall RR, editors. Handbook of clinical neurology, Vol. 12. Amsterdam: Elsevier; 1989. p. 543-80.
24. Reiner A., Albin R.L., Anderson K.D., D'Amato J.D., Penney J.B., Young A.B. Differential loss of striatal projection neurons in Huntington's disease. Proc Natl Acad Sci USA. 85:1988;5733-5737.
25. Richey P.L., Siedlak S.L., Smith M.A., Perry G. Apolipoprotein E interaction with neurofibrillary tangles and senile plaques in Alzheimer disease implications for disease pathogenesis . Biochem Bioph Res Co. 208:1995;657-663.
26. Sanan D.A., Weisgraber K.H., Russell S.J., et al. Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3. J Clin Invest. 94:1994;860-869.
27. Saunders A.M., Schmader K., Breitner J.C.S., et al. Apolipoprotein E4 allele distributions in late onset Alzheimer's disease and in other amyloid-forming diseases. Lancet. 342:1993;710-711.
28. Schneider J.A., Gearing M., Robbins R.S., de l'Aune W., Mirra S.S. Apolipoprotein E genotype in diverse neurodegenerative disorders. Ann Neurol. 38:1995;131-135.
29. Singhrao S., Neal J., Gasgue P., Morgan B., Newman G. Role of complement in the aetiology of Picks disease? J Neuropath Exp Neur. 55:1996;578-593.
30. Strittmatter W.J., Saunders A.M., Goedert M., et al. Isoform specific interactions of apolipoprotein E with microtubule-associated protein tau implications for Alzheimer disease . Proc Natl Acad Sci USA. 91:1994;11183-11186.
31. Watanabe M., Abe K., Aoki M. A reproducible assay of PCR to detect trinucleotide repeat expansion of Huntington's disease and senile chorea. Neurol Res. 18:1996;16-18.
32. Yasuhara O., Yoshinari A., McGeer E., McGeer P. Expression of the complement membrane attack complex and its inhibitors in Pick's disease brain. Brain Res. 652:1994;346-349.